CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Other Non Operating Income (2022 - 2026)

CDT Equity's (CDT) quarterly Other Non Operating Income came in at -$408000.0 in Q1 2026, down 137.67% YoY from $1.1 million in Q1 2025, and down 1306.9% on a QoQ basis from -$29000.0 in Q4 2025.

CDT Equity (CDT) Other Non Operating Income (2022 - 2026) Analysis & Trends

CDT Equity (CDT) has 5 years of Other Non Operating Income data on file, last reported at -$408000.0 in Q1 2026.

  • Quarterly Other Non Operating Income fell 137.67% year-over-year to -$408000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$318000.0 (down 279.66% YoY) and the FY2025 annual result came in at $970000.0, up 208.99% from the prior year.
  • Other Non Operating Income retreated to -$408000.0 in Q1 2026, from -$29000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $4.6 million in Q4 2023 to a low of -$1.4 million in Q4 2022.
  • A 5-year average of $440733.3 and a median of $58000.0 in 2024 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2025 — Other Non Operating Income jumped 3767.86% — and 2026, when it sank 137.67%.
  • Tracing CDT's Other Non Operating Income over 5 years: stood at -$1.4 million in 2022, then surged by 429.92% to $4.6 million in 2023, then tumbled by 122.93% to -$1.1 million in 2024, then surged by 97.26% to -$29000.0 in 2025, then slumped by 1306.9% to -$408000.0 in 2026.
  • The last three Other Non Operating Income figures came in at -$408000.0 (Q1 2026), -$29000.0 (Q4 2025), and $104000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CDT Equity 1.55 Mn 1.55 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.64 Mn
Mar 31, 2026 -408,000.00
Dec 31, 2025 -29,000.00
Sep 30, 2025 104,000.00
Jun 30, 2025 15,000.00
Mar 31, 2025 1.08 Mn
Dec 31, 2024 -1.06 Mn
Sep 30, 2024 58,000.00
Jun 30, 2024 93,000.00
Mar 31, 2024 28,000.00
Dec 31, 2023 4.61 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2023 270,000.00
Mar 31, 2023 -157,000.00
Dec 31, 2022 -1.40 Mn
Sep 30, 2022 95,000.00